Tenax Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference

CHAPEL HILL, N.C., March 31, 2025 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax Therapeutics” or the “Company”), a Phase 3, development-stage pharmaceutical company using clinical insights to develop novel cardiopulmonary therapies, today announced that the Company will present at the 24^th Annual Needham Virtual Healthcare Conference, which is taking place virtually from April 7-10, 2025.

Read more at globenewswire.com